Stock 603168 ZHEJIANG SHAPUAISI PHARMACEUTICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.

Equities

603168

CNE100001TG0

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
8.7 CNY +1.99% Intraday chart for Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. +1.87% -35.12%
Apr. 19 Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Apr. 17 Shapuaisi Pharma Gets China's Nod to Market Sodium Hyaluronate Eye Drops MT

Business Summary

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. is a China-based company principally engaged in the production, research, development and sale of chemical medicine and Chinese patent drugs. The Company's chemical medicine products mainly include Shapuaisi Bendazac Lysine Eye Drops, infusion products and cefixime products. The Company's Chinese patent drugs include kidney tonifying and nerve soothing products, such as Sizi Tianjing Capsules and Compound Gaoshan Hongjingtian Solution. The Company distributes its products in domestic market.

Number of employees: 1,241

Sales per Business

CNY in Million2022Weight2023Weight Delta
Commodity
72.7 %
385 70.1 % 469 72.7 % +21.84%
Clinical Services
26.2 %
155 28.2 % 169 26.2 % +9.16%
Other Business
1.1 %
10 1.8 % 7 1.1 % -29.03%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
550 100.0 % 645 100.0 % +17.37%

Managers

Managers TitleAgeSince
Biao Yan CEO
 Chief Executive Officer 42 20-08-27
Xiu Song Lin DFI
 Director of Finance/CFO 55 20-12-16
Kai Lin BRD
 Director/Board Member 30 23-05-18
Ming Xiong Huang BRD
 Director/Board Member 31 22-01-10
Xiao Feng BRD
 Director/Board Member 53 15-05-19
Jian Guo Wu BRD
 Director/Board Member 61 18-05-15
Zheng Guo Hu BRD
 Director/Board Member 58 -
Yu Wang IRC
 Investor Relations Contact 34 -

Members of the board

Members of the board TitleAgeSince
Guo Tong Xu BRD
 Director/Board Member 67 20-08-27
Wei Min Wang BRD
 Director/Board Member 73 10-04-01
Zheng Guo Hu BRD
 Director/Board Member 58 -
Jian Guo Wu BRD
 Director/Board Member 61 18-05-15
Yuan Lue Fu BRD
 Director/Board Member 71 20-08-27
Xiao Feng BRD
 Director/Board Member 53 15-05-19
Biao Yan CEO
 Chief Executive Officer 42 20-08-27
Ji Wei Sun BRD
 Director/Board Member 56 22-12-13
Xiao Sen Xu CHM
 Chairman 27 23-08-27
Xia Lu BRD
 Director/Board Member 33 23-05-18

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 379,161,625 174,217,120 ( 45.95 %) 6,547,620 ( 1.727 %) 45.95 %

Shareholders

NameEquities%Valuation
Truvalue Asset Management Co. Ltd.
0.002633 %
7,830 0.002633 % 10 953 ¥

Company contact information

Zhejiang Shapuaisi Pharmaceutical Co. Ltd.

1588 Xinming Road Economic Development Zone

314200, Pinghu

+

http://www.zjspas.com
address Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.(603168)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ZHEJIANG SHAPUAISI PHARMACEUTICAL CO.,LTD. Stock Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.
-35.12% 455M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 603168 Stock
  4. Company Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.